Koite Health Oy has received the EU Quality Management System Certificate in accordance with the European Medical Device Regulation. The certificate covers the company’s Class IIa equipment for the treatment and prevention of oral diseases caused or exacerbated by dental plaque – including Lumoral and Lumoral Junior devices and their accessories.
Finnish health technology company Koite Health is strengthening its position in Sweden and international markets with a new CEO, expanded pharmacy partnerships, and a new growth strategy.
The company’s patented Lumoral® innovation, designed to prevent oral and gum disease, is now expanding its distribution to the Swedish state-owned Apoteket AB’s product range, after the product has already established itself in the Apotek Hjärtat pharmacy chain.
Finnish health tech group Koite Health – named one of Europe’s hottest startup companies in 2022 – is proud to join the IDS Cologne event to showcase its Lumoral-method.
A major gingivitis study reveals – Finnish innovation treats and prevents periodontitis efficiently. The breakthrough study shows that eliminating the…
The Therapeutic Goods Administration (TGA) at Australia’ Department of Health is Australia’s regulatory authority. It assesses the performance, safety, quality…
Koite Health researchers have studied the efficacy and sustainability of the antibacterial effect of daily administered dual light on Streptococcus…
The Finnish public service media company, Yle News, features Koite Health’s Dual light innovation as an example of recent top…
(In english below) Viimeaikainen kehitys COVID-19 koronavirustilanteessa ja tartuntojen nopea leviäminen Suomessa on johtanut Koite Healthin päätökseen rajoittaa tapahtumaosallistumista toistaiseksi….
Finnish Medical Journal has featured Koite Health research. The journal is a general medical journal and the leading journal aimed at…
“The new method developed by Finnish researchers is based on dual-light photodynamic therapy. The method doesn’t interfere with friendly bacteria…